Correlation Between Arhaus and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Arhaus and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arhaus and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arhaus Inc and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Arhaus and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arhaus with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arhaus and Catalyst Pharmaceuticals.
Diversification Opportunities for Arhaus and Catalyst Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Arhaus and Catalyst is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Arhaus Inc and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Arhaus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arhaus Inc are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Arhaus i.e., Arhaus and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Arhaus and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Arhaus is expected to generate 2.98 times less return on investment than Catalyst Pharmaceuticals. In addition to that, Arhaus is 1.27 times more volatile than Catalyst Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest 1,587 in Catalyst Pharmaceuticals on October 27, 2024 and sell it today you would earn a total of 664.00 from holding Catalyst Pharmaceuticals or generate 41.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Arhaus Inc vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Arhaus Inc |
Catalyst Pharmaceuticals |
Arhaus and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arhaus and Catalyst Pharmaceuticals
The main advantage of trading using opposite Arhaus and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arhaus position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Arhaus vs. Floor Decor Holdings | Arhaus vs. Live Ventures | Arhaus vs. Haverty Furniture Companies | Arhaus vs. Home Depot |
Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |